InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by GALA RENEE D, Director. Director active across 2 companies, notably DEXCOM INC. Cumulatively, 4 disclosures have been recorded. The latest transaction was filed on 8 May 2025 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations4 total
01,161 shares0
Common Stock
SEC:0001093557-25-000224·
01,161 shares0
Common Stock
SEC:0001093557-25-000224:0·
€243,8771,633 shares@ €149.34310.0017% mcap100.0% of flow
Ordinary Shares
SEC:0001765581-22-000038:0·
011,730 shares0
Ordinary Shares
SEC:0001765581-22-000017:0·
4 of 4 declarations
About GALA RENEE D
Renee D. Gala serves as Director, Executive Vice President, and Chief Financial Officer at Dexcom Inc. and Jazz Pharmaceuticals plc. She is responsible for the financial management of these companies, overseeing financial and strategic operations. Her expertise in finance and accounting is crucial for informed decision-making within both organizations.
